Technical Analysis for ATXI - Avenue Therapeutics, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Historical ATXI trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Slingshot Bearish | Bearish Swing Setup | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Slingshot Bearish | Bearish Swing Setup | 1.98% | |
| Stochastic Buy Signal | Bullish | 1.98% | |
| Lower Bollinger Band Walk | Weakness | 1.98% | |
| Outside Day | Range Expansion | 1.98% | |
| Wide Bands | Range Expansion | 1.98% | |
| Lower Bollinger Band Touch | Weakness | 1.98% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| Rose Above Previous Day's High | about 17 hours ago |
| Down 3% | about 17 hours ago |
| Down 2 % | about 17 hours ago |
| Down 1% | about 17 hours ago |
| Up 5% | about 17 hours ago |
Free Daily (Stock) Chart Reading
- Earnings date: 09/27/2019
Avenue Therapeutics, Inc. Description
Avenue Therapeutics, Inc. is a pharmaceutical company. The Company is engaged in acquiring, licensing, developing and commercializing products principally for use in the acute or intensive care hospital setting. Its product candidate is intravenous (IV) Tramadol, an intravenous formulation of tramadol hydrochloride (HCl), for the management of moderate to moderately severe postoperative pain. Tramadol, a synthetic dual-acting opioid, is a centrally acting analgesic with weak opioid agonist properties. It also works via the inhibition of serotonin and noradrenaline re-uptake and blocking nociceptive impulses at the spinal level. Tramadol is also combined with acetaminophen (APAP) or nonsteroidal anti-inflammatory drugs (NSAIDS) in clinical practice. During the year ending December 31, 2016, the Company had completed a pharmacokinetics (PK) study for IV Tramadol in healthy volunteers.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Pharmaceutical Drugs Chemical Compounds Chloride Opioid Amines Analgesics Neurochemistry Hepatotoxins Pharmacokinetics Paracetamol Nonsteroidal Anti Inflammatory Drug
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 12.3398 |
| 52 Week Low | 2.85 |
| Average Volume | 339,971 |
| 200-Day Moving Average | 7.02 |
| 50-Day Moving Average | 5.82 |
| 20-Day Moving Average | 5.60 |
| 10-Day Moving Average | 5.09 |
| Average True Range | 0.63 |
| ADX | 21.79 |
| +DI | 16.24 |
| -DI | 26.02 |
| Chandelier Exit (Long, 3 ATRs ) | 5.65 |
| Chandelier Exit (Short, 3 ATRs ) | 5.74 |
| Upper Bollinger Band | 7.42 |
| Lower Bollinger Band | 3.79 |
| Percent B (%b) | 0.23 |
| BandWidth | 64.81 |
| MACD Line | -0.45 |
| MACD Signal Line | -0.26 |
| MACD Histogram | -0.1863 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 5.27 | ||||
| Resistance 3 (R3) | 5.26 | 5.04 | 5.17 | ||
| Resistance 2 (R2) | 5.04 | 4.88 | 5.05 | 5.13 | |
| Resistance 1 (R1) | 4.84 | 4.78 | 4.94 | 4.85 | 5.09 |
| Pivot Point | 4.62 | 4.62 | 4.67 | 4.63 | 4.62 |
| Support 1 (S1) | 4.42 | 4.46 | 4.52 | 4.43 | 4.19 |
| Support 2 (S2) | 4.20 | 4.36 | 4.21 | 4.15 | |
| Support 3 (S3) | 4.00 | 4.20 | 4.12 | ||
| Support 4 (S4) | 4.01 |
